Abstract
Inorganic arsenic exposure is ubiquitous, and both exposure and interindividual differences in its metabolism have been associated with cardiometabolic risk. However, the associations of arsenic exposure and arsenic metabolism with the metabolic syndrome (MetS) and its individual components are relatively unknown. We used Poisson regression with robust variance to evaluate the associations of baseline arsenic exposure (urinary arsenic levels) and metabolism (relative percentage of arsenic species over their sum) with incident MetS and its individual components (elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension, and elevated fasting plasma glucose) in 1,047 participants from the Strong Heart Family Study, a prospective familybased cohort study in American Indian communities (baseline visits were held in 1998-1999 and 2001-2003, followup visits in 2001-2003 and 2006-2009). Over the course of follow-up, 32% of participants developed MetS. An interquartile-range increase in arsenic exposure was associated with a 1.19-fold (95% confidence interval: 1.01, 1.41) greater risk of elevated fasting plasma glucose concentration but not with other individual components of the MetS or MetS overall. Arsenic metabolism, specifically lower percentage of monomethylarsonic acid and higher percentage of dimethylarsinic acid, was associated with higher risk of overall MetS and elevated waist circumference but not with any other MetS component. These findings support the hypothesis that there are contrasting and independent associations of arsenic exposure and arsenic metabolism with metabolic outcomes which may contribute to overall diabetes risk.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1598-1612 |
| Number of pages | 15 |
| Journal | American Journal of Epidemiology |
| Volume | 187 |
| Issue number | 8 |
| DOIs | |
| State | Published - Jan 1 2018 |
Fingerprint
Keywords
- American Indians
- Arsenic
- Arsenic metabolism
- Indigenous populations
- Metabolic syndrome
- Prospective cohort studies
ASJC Scopus subject areas
- Epidemiology
Cite this
The association of arsenic exposure and arsenic metabolism with the metabolic syndrome and its individual components : Prospective evidence from the strong heart family study. / Spratlen, Miranda J.; Grau-Perez, Maria; Best, Lyle G.; Yracheta, Joseph; Lazo-Elizondo, Mariana; Vaidya, Dhananjay; Balakrishnan, Poojitha; Gamble, Mary V.; Francesconi, Kevin A.; Goessler, Walter; Cole, Shelley A.; Umans, Jason G.; Howard, Barbara V.; Navas Acien, Ana.
In: American Journal of Epidemiology, Vol. 187, No. 8, 01.01.2018, p. 1598-1612.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - The association of arsenic exposure and arsenic metabolism with the metabolic syndrome and its individual components
T2 - Prospective evidence from the strong heart family study
AU - Spratlen, Miranda J.
AU - Grau-Perez, Maria
AU - Best, Lyle G.
AU - Yracheta, Joseph
AU - Lazo-Elizondo, Mariana
AU - Vaidya, Dhananjay
AU - Balakrishnan, Poojitha
AU - Gamble, Mary V.
AU - Francesconi, Kevin A.
AU - Goessler, Walter
AU - Cole, Shelley A.
AU - Umans, Jason G.
AU - Howard, Barbara V.
AU - Navas Acien, Ana
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Inorganic arsenic exposure is ubiquitous, and both exposure and interindividual differences in its metabolism have been associated with cardiometabolic risk. However, the associations of arsenic exposure and arsenic metabolism with the metabolic syndrome (MetS) and its individual components are relatively unknown. We used Poisson regression with robust variance to evaluate the associations of baseline arsenic exposure (urinary arsenic levels) and metabolism (relative percentage of arsenic species over their sum) with incident MetS and its individual components (elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension, and elevated fasting plasma glucose) in 1,047 participants from the Strong Heart Family Study, a prospective familybased cohort study in American Indian communities (baseline visits were held in 1998-1999 and 2001-2003, followup visits in 2001-2003 and 2006-2009). Over the course of follow-up, 32% of participants developed MetS. An interquartile-range increase in arsenic exposure was associated with a 1.19-fold (95% confidence interval: 1.01, 1.41) greater risk of elevated fasting plasma glucose concentration but not with other individual components of the MetS or MetS overall. Arsenic metabolism, specifically lower percentage of monomethylarsonic acid and higher percentage of dimethylarsinic acid, was associated with higher risk of overall MetS and elevated waist circumference but not with any other MetS component. These findings support the hypothesis that there are contrasting and independent associations of arsenic exposure and arsenic metabolism with metabolic outcomes which may contribute to overall diabetes risk.
AB - Inorganic arsenic exposure is ubiquitous, and both exposure and interindividual differences in its metabolism have been associated with cardiometabolic risk. However, the associations of arsenic exposure and arsenic metabolism with the metabolic syndrome (MetS) and its individual components are relatively unknown. We used Poisson regression with robust variance to evaluate the associations of baseline arsenic exposure (urinary arsenic levels) and metabolism (relative percentage of arsenic species over their sum) with incident MetS and its individual components (elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension, and elevated fasting plasma glucose) in 1,047 participants from the Strong Heart Family Study, a prospective familybased cohort study in American Indian communities (baseline visits were held in 1998-1999 and 2001-2003, followup visits in 2001-2003 and 2006-2009). Over the course of follow-up, 32% of participants developed MetS. An interquartile-range increase in arsenic exposure was associated with a 1.19-fold (95% confidence interval: 1.01, 1.41) greater risk of elevated fasting plasma glucose concentration but not with other individual components of the MetS or MetS overall. Arsenic metabolism, specifically lower percentage of monomethylarsonic acid and higher percentage of dimethylarsinic acid, was associated with higher risk of overall MetS and elevated waist circumference but not with any other MetS component. These findings support the hypothesis that there are contrasting and independent associations of arsenic exposure and arsenic metabolism with metabolic outcomes which may contribute to overall diabetes risk.
KW - American Indians
KW - Arsenic
KW - Arsenic metabolism
KW - Indigenous populations
KW - Metabolic syndrome
KW - Prospective cohort studies
UR - http://www.scopus.com/inward/record.url?scp=85047238854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047238854&partnerID=8YFLogxK
U2 - 10.1093/aje/kwy048
DO - 10.1093/aje/kwy048
M3 - Article
C2 - 29554222
AN - SCOPUS:85047238854
VL - 187
SP - 1598
EP - 1612
JO - American Journal of Epidemiology
JF - American Journal of Epidemiology
SN - 0002-9262
IS - 8
ER -